Proteus Digital Health, Inc.

Otsuka Pharmaceutical Company, Limited

Vium, Inc.

Recursion Pharmaceuticals, Inc.

Precision Livestock Technologies, Inc.

Timothy Robertson

Mark Zdeblick

Hooman Hafezi

Benedict Costello

George M Savage

Yashar Behzadi

Aleksandr Pikelny

Andrew S Thompson

Lawrence W Arne

David O'Reilly

Robert Duck

Olivier K Colliou

Jonathan Betts-Lacroix

Patricia Johnson

Eric Snyder

Andrew Thompson

Robert C Leichner

Kit Yee Au-Yeung

Kenneth C Crandall

Zahedeh Hatamkhany

Maria Holen

Kityee Au-Yeung

Marc S Kreidler

Todd Thompson

Raymond H Schmidt

James Hutchison

Fataneh Omidvar

Brad Cozad

Kenneth Rowberry

Laura R Schaevitz

Patrick Beaulieu

Jeremy Frank

Tariq Haniff

Arna Diana Ionescu

Marc Jensen

Kyle Howard Heath

Danielle Schulze Cojuangco

Mark J Zdeblick

Gregory Moon

Erika Karplus

David O'reilly

Robert Azevedo

Aaron Samuel Filner

Kurt Scheinpflug

Richard Huang

Sara Burgess

Robert Leichner

Larry Stevens

Rod Nicholas

Ricardo Alexandre Esteves Mendonca

Maria Casillas Holen

Alexander Pikelny

Oliver Colliou

A target authentication device includes an electrode to detect an electrical signal associated with a user of the device. The electrical signal represents an authentication code for the device. An authentication receiver module is coupled to the electrode. The module receives the electrical signal from the electrode and determines whether the electrical signal matches a predetermined criterion to authenticate the identity of the user based on the electrical signal. An authentication module is also disclosed. The authentication module includes one electrode to couple an electrical signal associated with a user to a user of a target authentication device, the electrical signal represents an authentication code for the device. An authentication transmission module is coupled to the electrode. The authentication transmission module transmits the electrical signal from the electrode. A method of authenticating the identity of a user of a target authentication device also is disclosed.

Personal authentication apparatus system and method

An electronic monitor can monitor experimental animals in a cage. The cage has one or more walls that enclose a living space for the experimental animals. The electronic monitor is coupled to the cage. The electronic monitor may include a housing adapted to be mechanically coupled to the cage in a predefined position relative to the cage. A substantially sterile barrier is provided between the living space and the external environment in this coupled state. The walls of the cage may include a signal-interface section. An electromagnetic detector may be coupled to the housing to have a line-of-sight through the signal-interface section and into the living space of the cage. The electromagnetic detector is adapted to detect electromagnetic radiation that is transmitted through the signal-interface section. A controller processes a signal received from the electromagnetic detector to determine a status of the experimental animals or the living space.

Electronic monitor for experimental animals

Transbody communication systems employing communication channels are provided. Various aspects include, for example, an in vivo transmitter to transmit an encoded signal; a transbody functionality module to facilitate communication of the encoded signal; and a receiver to receive the encoded signal. Methods and apparatus are also provided.

Transbody communication systems employing communication channels

A system and method are disclosed for training a system or a model to allow estimation of the value of livestock that is farmed for monetary gain. The various aspects of the invention include generation of data that is used to supplement or augment capture or real data, wherein the subject of the data is an animal. Labels or attributes are generated and validated.

System and method to analyse an animal's image for market value determination

An apparatus that includes a partial power source including a first material and a second material, the partial power source configured to generate, upon contact with a conducting medium, a potential difference between the first material and the second material to provide power to a control device, and generate, using the first material and the second material, a current flow within the conducting medium, the current flow including information encoded based on a variable conductance between the first material and the second material.

Pharma-informatics system

Power sources that enable in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body power sources of the invention include a solid support, a first high surface area electrode and a second electrode. Embodiments of the in-power sources are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the power sources of the invention.

In-body power source having high surface area electrode

Apparatuses for use with a pharmaceutically acceptable carrier. The apparatus can include a partial power source, which in turn includes electrodes or materials that are configured to generate an electrical potential upon contacting or being exposed to an ionic solution. The apparatus can further include a circuit electrically or communicatively coupled to the partial power source. The circuit can generate various types of signals, such as RF signals, when powered by the partial power source. The circuit is stably fittable to the pharmaceutically acceptable carrier. The apparatus can further include a barrier, a protective layer, or a membrane that isolates the electrodes or materials from the ionic solution and is configured to be dissolved by the ionic solution.

Controlled activation ingestible identifier

The ingestible event marker data framework provides a uniform, comprehensive framework to enable various functions and utilities related to ingestible event marker data (IEM data). The functions and utilities include data and/or information having an aspect of data derived from, collected by, aggregated by, or otherwise associated with, an ingestion event.

Ingestible event marker data framework

The present invention discloses multiple approaches to preventing the capsule walls and other material from interfering with the performance of an electronic device once the device is activated by surrounding fluid. In accordance with the teachings of the present invention, a miniature ingestible device (MID) may be created using excipients and films. The MID, in accordance with various aspects of the present invention, will have a coating or laminating surrounding an electronic device and separating and isolating the device from the pharmaceutical product or drug within the capsule once the capsule is ingested as well as from the capsule itself as the capsule walls begin to collapse during the disintegration process.

Miniature ingestible device

The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can be used in a variety of different applications, including as components of ingestible identifiers, such as may be found in ingestible event markers, e.g., pharma-informatics enabled pharmaceutical compositions.

Communication system with partial power source

A system for administering prescription medications including a composition and a receiver. The composition may include an active agent, an identifier, and a pharmaceutically acceptable carrier. The active agent may include a controlled pharmaceutical. The identifier may include: a partial power source having a first material and a second material configured to generate a voltage in contact with a conductive fluid within a body of a patient, and a signal generation component configured to use at least a portion of the generated voltage to transmit a signal through the body of the patient. The receiver may be positioned near the body of the patient, wherein the receiver is configured to: receive the signal transmitted through the body of the patient, and automatically report the signal for at least one of identification of the controlled pharmaceutical or tracking physical administration of the controlled pharmaceutical to the body of the patient.

Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane.

Highly reliable ingestible event markers and methods for using the same

Growing community of inventors

Belmont, CA, United States of America

Timothy Robertson